Informing the Population of Their Level of Protection Against COVID-19 in Monaco: a Prospective Study (MonaVacc)

• Conditions: COVID-19; Vaccines; Antibody; SARS-CoV-2

• Registration Number: NCT05084950
• Lead Sponsor: Centre Scientifique de Monaco

Brief Summary

Vaccines against the coronavirus type 2 causing severe acute respiratory syndrome Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) have been created in a short period of time due to the rapid spread of the virus. These vaccines use different and sometimes innovative technologies, such as the use of ribonucleic acid (RNA), or a non-replicating viral vector. Efficacy ranging from 70-90% in the first weeks after the second injection of these vaccines has been reported, with side effects whose causality remains to be determined.

Detailed Description

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Study Timeline

• Study Start: 2021-07-01
• Status Verified: 2021-10
• Study First Submitted: 2021-10-19
• Study First Submitted QC: 2021-10-19
• Last Update Submitted: 2021-10-19
• Study First Posted: 2021-10-20
• Last Update Posted: 2021-10-20
• Primary Completion: 2022-12-31
• Study Completion: 2022-12-31

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 10000

Inclusion Criteria

• Participant must live in the Principality of Monaco
• Deliver a written consent to participate to the study
• And/Or Have been infected with SARS-CoV-2
• And/Or Have been, or are about to be, vaccinated against SARS-CoV-2

Exclusion Criteria

• None of the above

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Covid-19 Neutralizing Antibodies Measurment	24-month period	Inform any individual who has been infected with or vaccinated against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) have about their level of immune protection, through a bi-annual follow-up

Trial Locations

Locations (1)

Centre National de Depistage - Espace Leo Ferre; 🇲🇨 Monaco, Monaco